Introduction
Tonsillectomy is one of the most commonly performed procedures in the pediatric population. 1 Although it is usually a safe procedure, complications include bleeding, dehydration, postoperative pain, and visits to the emergency department. Bleeding can potentially be life threatening and may necessitate reoperation.
1,2 Postoperative pain and dehydration have also received attention in the literature as preventable complications. 2 The effect of several medications on the incidence of these complications has been studied. Nonsteroidal anti-inflammatory drugs have been reported to be associated with an increased risk of bleeding and reoperation rates, 3, 4 although recent literature has provided evidence to refute this claim. 5 Steroid use in the post-tonsillectomy patient also has been debated, with steroids demonstrated to decrease postoperative pain and bleeding risk in one study but to increase the frequency of reoperation or post-tonsillectomy hemorrhage in another study. 6, 7 Complications associated with other, less frequently used forms of analgesia, including topical anesthetics, have not been formally studied; however, they have been reported to reduce pain severity up to the third postoperative day in some patients. 8 The effects of long-term medications, such as those for the treatment of attention deficit hyperactivity disorder (ADHD) and allergy medications, including montelukast, have not been studied in this context. To our knowledge, no studies have been performed to assess post-tonsillectomy outcomes of patients who take either ADHD medications or montelukast. One recent study has, however, assessed the potential utility of montelukast in postoperative pain control in post-tonsillectomy patients. 9 A selection of ADHD medications was included in our study because of the frequency of use among our patients.
The aim of this study was to investigate complications such as post-tonsillectomy hemorrhage, dehydration, and visits to the emergency department (ED) in patients who are prescribed these commonly used medications (ibuprofen, steroids, topical anesthetics, montelukast, and ADHD medications) around the time of surgery. This study will help to close gaps in knowledge regarding the effects of these medications on outcomes of patients after tonsillectomy and to improve patient care.
Patients and methods
This study was reviewed by the Penn State Hershey Medical Center Institutional Review Board and determined to be review-exempt.
The data source was the MarketScan Commercial Claims and Encounters (Truven) database, which contains reimbursed claims from more than 130 payers for more than 56 million individuals covered annually under private insurance plans. The database includes fully integrated patient-level data (inpatient, outpatient, pharmaceutical, laboratory, and associated healthcare costs) from all regions of the United States.
All data from the Truven database are deidentified in compliance with the Health Insurance Portability and Accountability Act of 1996. Data were extracted for patients with an inpatient or outpatient claim indicating tonsillectomy between the years of 2008 and 2012.
Tonsillectomy was determined from claims with CPT codes 42820, 42821, 42825, 42826, and International Classification of Diseases, 9th revision, Clinical Modification (ICD-9) procedure codes 28.2, 28.3. For patients with multiple claims for tonsillectomy, only the first claim by date was used for the analysis.
Data were included for patients 1 to 17 years old who had a length of surgical stay ≤14 days. This length of stay was chosen to exclude patients likely to have excessive morbidity. Each patient was enrolled in an insurance plan from 30 days before surgery to 14 days after discharge.
Pharmaceutical claims were searched for several prescription drug classes including topical anesthetics, ibuprofen, montelukast, steroids, and ADHD medications. Pharmaceutical claims included prescriptions that were filled by the patients as outpatients and therefore paid for by their insurance companies. Table 1 shows the generic names used to identify claims for these drug classes. Drug classes were divided into two categories: short-term medications, including topical anesthetics, ibuprofen, and steroids; and long-term medications, including montelukast and ADHD medications.
For short-term medications, patients who had a pharmaceutical claim from 1 day before surgery to the date of discharge were classified as having received the drug. The short time frame was intended to exclude medications prescribed in response to a postoperative complication (bleeding, dehydration, or ED visit). For long-term medications, patients who had a pharmaceutical claim from 30 days before the date of surgery to 14 days after the date of discharge were classified as having received the drug. The longer time frame was used because these drugs are used chronically and not as a response to postoperative complications, and prescriptions would usually be filled at regular intervals of at least 1 month.
The following four outcomes were evaluated: bleeding complication, dehydration, ED visits, and readmission. Outcomes were based on inpatient and outpatient claims that occurred from 1 to 14 days after discharge. A bleeding complication was identified using CPT codes 42960-42962, ICD-9 procedure code 28.7, and ICD-9 diagnosis codes 998.11 and 784.8. Dehydration was identified using ICD-9 diagnosis codes 276.50 and 276.51. An ED visit was identified from the last two digits of the "service subcategory code" provided in the MarketScan database being equal to 20. A readmission was defined as any inpatient claim (for any reason) within 14 days after discharge.
All statistical analysis was conducted separately for each drug class. In univariate analysis, postoperative outcomes were compared for patients who did and did not receive a prescription for the given drugs. Chisquare tests were used to determine whether outcomes differed by use of each drug. In multivariate analysis, separate logistic regression models were used to model outcomes by a given drug class while simultaneously adjusting for age at surgery, gender, surgical setting (inpatient versus outpatient), year of surgery, and length of surgical stay.
In each model, age and surgical year were modeled using b-splines with 3 degrees of freedom to allow for nonlinear relationships with the outcome; length of stay was assumed to be linear (a reasonable assumption based on exploratory plots); and gender and surgical setting were modeled as categorical variables with reference categories. Odds ratios (ORs) and 95% confidence intervals (CIs) for the primary factor of prescription drug status (received vs. did not receive) were reported for each drug and each outcome.
Results
A total of 306,536 patients met all inclusion criteria and formed the study population. Patients had a median age of 6 years, 51.4% were female, and 98% had a tonsillectomy in an outpatient setting (table 2) . From 1 day before surgery through the day of discharge, topical anesthetics were prescribed for 3,679 patients (1.2%), ibuprofen was prescribed for 1,206 patients (0.4%), and steroids were prescribed for 12,892 patients (4.2%).
Among the long-term medications, 4,203 patients (1.4%) were prescribed ADHD drugs and 8,433 (2.8%) were prescribed montelukast from 30 days before surgery to 14 days after discharge. The figure shows the percentages of patients with each drug by age. Steroids were the most commonly prescribed medication, with a higher percentage of mid-to late-teenage patients prescribed steroids compared with other age groups. The use of topical anesthetics was also more prevalent in the mid-to late-teenage population. Montelukast prescriptions decreased as age increased, whereas ADHD medication prescriptions increased with age.
Within 14 days after discharge 8,720 patients (2.8%) had a bleeding complication, 8,170 patients (2.7%) had dehydration, 21,132 patients (6.9%) had an ED visit, and 3,558 patients (1.2%) had a readmission. Those who were prescribed ibuprofen had significantly higher likelihood of bleeding within 14 days than those not prescribed ibuprofen (3.8 vs. 2.7%, p < 0.001). A significantly smaller percentage of patients receiving steroids experienced dehydration (1.9 vs. 2.7%, p < 0.001), had ED visits (5.9 vs. 6.9%, p < 0.001), and required readmissions (0.8 vs. 1.2%, p < 0.001) within 14 days compared with patients not receiving steroids.
A significantly higher percentage of patients prescribed ADHD medications had ED visits versus those not prescribed ADHD medications (8.1 vs. 6.9%, p = 
Discussion
Complications after tonsillectomy have been studied extensively in the literature. Post-tonsillectomy hemorrhage occurs in about 0.2 to 2.2% of patients; 3.9% of patients require readmission and 3.0 to 5.0% of patients have postoperative dehydration. 3, 10 The relationship between medications and post-tonsillectomy complications has been questioned, especially with respect to analgesics. The call for alternative methods of pain control in post-tonsillectomy patients came after reported fatalities related to codeine use after tonsillectomy. 11, 12 In the search for alternative means of pain control, ibuprofen has been used with increasing frequency. Ibuprofen is a reversible inhibitor of cyclo-oxygenase, therefore concern for possible effects on platelet function exists, although no significant effect on bleeding time has been found in patients with normal coagulation systems. 13 The issue of nonsteroidal anti-inflammatory drug (NSAID)-related bleeding has resulted in several studies examining ibuprofen and post-tonsillectomy outcomes. In the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Clinical Practice Guideline: Tonsillectomy in Children, meta-analyses are cited that show both an increased and an equivocal risk of post-tonsillectomy hemorrhage with the use of ibuprofen. 3 Overall, however, the AAO-HNS reports ibuprofen to be a safe means of pain control for patients after tonsillectomy. 3 In the meta-analyses cited, the rate of post-tonsillectomy bleeding ranged from 3.5 to 8.4%, [13] [14] [15] with no significant difference in bleeding rates in patients given either ibuprofen alone or in combination with acetaminophen. 15 A similar conclusion was made in a more recent meta-analysis, which found that the use of NSAIDs in comparison with other means of pain control, including opioids and placebos, have no increased risk of post-tonsillectomy hemorrhage. 16 In other reports, the need for control of bleeding in the operating room was not significantly different between patients receiving ibuprofen (1.5%) and those patients not receiving ibuprofen (0.8%). 15 In our study, which included more than 1,200 children prescribed ibuprofen, a significantly elevated odds ratio of 1.45 for bleeding post-tonsillectomy was found, 15 raising concern that bleeding and ibuprofen are related. The use of ibuprofen for post-tonsillectomy pain control needs more study.
Steroids have been shown to decrease the incidence and severity of pain and nausea; however, the risks of post-tonsillectomy hemorrhage with steroids have also been significant. 2 In recent studies, administration of steroids in the postoperative period increased the frequency of reoperation secondary to increased rates of post-tonsillectomy hemorrhage. 7 A meta-analysis of 29 randomized, controlled trials found a significantly higher rate of operative intervention for post-tonsillectomy hemorrhage in patients receiving systemic steroids (OR: 2.27, 95% CI: 1.03 to 4.99) compared with those not receiving steroids. 7 The authors of this meta-analysis
Figure. Graphs show the percentage of patients with prescriptions for each drug by age for (A) drug claims from 1 day before surgery through discharge (short-term medications), and (B) drug claims from 30 days before surgery through discharge (long-term medications).
concluded, however, that steroid administration did not increase the overall incidence of bleeding in the patients receiving steroids (OR: 0.96, 95% CI: 0.66 to 1.40). 7 Another meta-analysis that included 12 studies revealed no increase in bleeding rates with administration of dexamethasone at doses ranging from 0.4 to 0.6 mg/kg. 6 In our study, we found no evidence of worsening of outcomes among children prescribed steroids before discharge. Our data do not include children who received in-hospital steroids. Indication for steroid prescription was not available in the database we used, so it is likely that some or many of these prescriptions were dispensed for the treatment of asthma (topical steroids were not included). We found that children prescribed outpatient steroids for any reason were significantly less likely to be diagnosed with dehydration, have an ER visit, or be readmitted after tonsillectomy. They were no more likely to have a postoperative bleed than were children who were not prescribed steroids. Although these data are not sufficient for clinicians to start prescribing outpatient steroids for post-tonsillectomy patients, the data should reassure them that the steroids children may be taking for other reasons should not increase the risk of common post-tonsillectomy complications.
Few studies have been performed regarding outcomes of patients using montelukast. One recent study made the claim that a preemptive single dose of montelukast may improve post-tonsillectomy pain control. 9 The proposed mechanism for analgesic action is a reduction of neutrophil degranulation resulting from reduced neutrophil migration. Interestingly, this single study did show a significant subjective decrease in pain intensity in patients administered a dose of montelukast 8 hours before surgery. 9 In our study, 8,433 children who were prescribed montelukast for up to 30 days before tonsillectomy and up to 14 days after surgery, presumably for the treatment of asthma and allergies, were included. Our results did not show an increase in postoperative bleeding, but these children were significantly more likely to be diagnosed with dehydration or have an ER visit or readmission within 14 days after surgery. The latter two outcomes may be related to the asthma or allergies for which the montelukast was prescribed, but it is not clear that dehydration would be related to either.
Topical anesthetics, including lidocaine spray, have been similarly found to reduce pain intensity; 8 however, their association with complications is unknown. We found that in the 3,659 patients for whom lidocaine spray was prescribed, the odds of a dehydration diagnosis after tonsillectomy were significantly higher. Perhaps the patients prescribed topical anesthetics were not doing well with pain control even before their discharge, thereby putting them at a higher risk of dehydration. Regardless of the reason for prescribing this medication, we have no evidence that employing topical anesthetics improved outcomes.
Additionally, to the authors' knowledge, no studies have been reported in the literature to describe the association between ADHD medications and post-tonsillectomy complications. In our hospital, we frequently encounter patients taking these medications. We found no difference in bleeding in recipients of ADHD medications, but these children had significantly higher odds of being diagnosed with postoperative dehydration and higher odds of an ED visit. These concerns could be explained by the underlying behavioral diagnoses that necessitate prescription of these medications.
It is helpful for clinicians to know that children on ADHD medications are more likely to have postoperative issues, if only so they can counsel parents appropriately. Our study provides the first evidence of complications related to these medications or their related disorders. Especially for older children, a better understanding of the effects of these factors on postsurgical outcomes is needed, as these age groups are treated with ADHD medications most often (figure).
This study is limited by the use of insurance/reimbursement claims to define medication use. Whether patients actually took the medications that had been prescribed and bought is unknown. Patients also might have been taking medications that were not prescribed to them, such as over-the-counter ibuprofen.
Causation of the outcomes cannot be claimed based on our analysis, and identifying causation was not our goal. Outcomes based on assessment of pain could not be reviewed in our study, as data on clinical pain assessment were not available in the MarketScan database. Our findings are useful for determining the areas that may require further examination, such as the increased bleeding observed with recipients of ibuprofen prescriptions.
The MarketScan database is limited to privately insured children; 6.2% of American children were uninsured in 2014. 17 We know that uninsured children are less likely to receive medications prescribed at an ED visit, 18 but their response to those medications would not be expected to differ from those of insured children. Therefore, our results are likely generalizable.
Conclusion
The most important findings of this study were that children who received prescriptions for ibuprofen were more likely to experience post-tonsillectomy bleeding, and children who received steroid prescriptions were less likely to have dehydration, an ED visit, or readmission within 14 days of tonsillectomy. The use of ibuprofen and steroids in this setting merits further examination. Clinicians employing ibuprofen in their practice may want to be attentive to choosing recipients carefully.
